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Objectives:Type IV (T4) thoracoabdominal aneurysm
repair despite low risk of spinal cord ischemia (SCI) is
reported to have significant morbidity and mortality. This
study evaluated clinical outcomes to identify predictors of
major morbidity in T4 repair.
Methods: All T4 repairs at MGH from 1/89 - 9/09
were evaluated with respect to clinical features, technical
operative details and 30-day outcomes. Logistic regression
identified predictors of morbidity and survival was assessed
using Kaplan-Meier.
Results: 179 patients underwent T4 repair with elec-
tive repair in 156 (87%) and urgent in 23 (13%). All
operations were conducted with clamp/sew technique and
routine hypothermic renal perfusion. Clinical features were
age 73 8, male 113 (63%), prior CVA 23 (13%), CAD 90
(50%) and Cr 1.8 (CRI) 26 (15%). Aneurysm (size 6.2
1.1cm) pathology was degenerative in 174 (97%). Opera-
tive reconstruction consisted of a beveled proximal anasto-
mosis incorporating the celiac, SMA, and right renal arter-
ies origins (visceral clamp 35 11min) and a side-arm graft
to the left renal artery in 166 (93%). Technical details
included previous AAA repair in 52 (29%), OR time 290
90min, EBL 2.4 1.4l and splenectomy 56 (31%). 30-day
outcomes were mortality 5 (2.8%), MI 5 (2.8%), pulmo-
nary 30 (17%), any renal comp. 36 (20%), hemodialysis 5
(2.8%) and SCI 4 (2.2%). Univariate predictors of compli-
cations included eGFR (p  0.02) and CRI (p  0.02),
while CVA (p  0.02), visceral clamp time (p  0.04) and
any complication (p  0.01) predicted 30-day mortality.
History of CRI independently predicted postoperative
complication or death (OR 3.0 [95% CI: 1.6-8.8]). One-,
five- and ten-year survival rates were 89 2%, 64 4% and
35  5%, respectively. Post-operative SCI increased long-
term mortality (OR 17 [95% CI: 3.6-83]).
Conclusions: T4 TAA repair is associated with favor-
able perioperative results. The evident significance of CRI
should figure prominently in clinical decision making. Pa-
tients who survive the physiologic stresses of repair have
favorable long-term survival.
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Objectives: Although EVAR is reputable as affording
superior perioperative and mid-term survival than OSR,
approximately 50% of AAAs are anatomically unsuitable for
EVAR using contemporary devices. We aim to gauge ex-
tending use of current commercially-available devices for
pararenal AAAs compared to the current standard OSR.
Primary Endpoints were aneurysm related survival and cost
per Quality-Adjusted-Life Years (QALY).
Methods: From 2002-2009, 1868 patients with AAA
were seen at our unit. 118 patients had intervention for
pararenal AAAs which were reported by consultant radiol-
ogists as ‘unsuitable for EVAR’. 66 of these had OSR and
52 had PEVAR. The PEVAR group was older (74.3 years
vs 70.9 years, p  0.004) with significantly higher mean
SVS co-morbidity scores (p  0.002) and Kertai Probabil-
ity Indices (p 0.004). All procedures were done within 14
days of diagnosis. Mean aneurysm diameter was signifi-
cantly higher for PEVAR (7.9cm vs 6.2cm, p  0.002).
83% of PEVAR endografts were 36mm diameter. All OSR
were done with diagonal proximal clamp, preserving flow
to the highest renal artery. Renal arteries were re-implanted
in five cases and the IMA once
Results: 5-year aneurysm-related survival rates were
higher with PEVAR (98% vs 92.4%, P0.05), although this
did not reach statistical significance. 5-year freedom from
secondary intervention was similar between PEVAR
(88.7%) and OSR (98%, P0.05). 5-year all-cause survival
was also statistically similar (PEVAR, 44.2% vs OSR 80.4%,
p  0.155). 5-year intervention-free survival was shy of
significance with PEVAR (48.5%) vs OSR (76.8.4%, p 
0.0503). 30-day morbidity (p  0.0002), Length of hos-
pital stay (p  0.0005), 5-year Q-TWiST (p  0.01) and
cost per QALY (p  0.01) were all significantly reduced
with PEVAR vs OSR.
Conclusions: Endografts can be effectively used to
treat difficult pararenal AAAs with acceptable long-term
aneurysm-related survival and enhanced cost per QALY
and reduced perioperative morbidity, mortality and waiting
time from diagnosis to treatment.
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